Skip to main content
PFSA
NASDAQ Life Sciences

Profusa Amends $1.87M Note to Convertible Equity with 19.99% Dilution Cap; Warrants Also Modified

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.54
Mkt Cap
$2.388M
52W Low
$0.41
52W High
$975.003
52W Position info
32% above low
Off High info
100% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

PFSA sits 32% above its 52-week low of $0.41 on light trading volume (0.2× avg).

Summary

Profusa has modified its $1.87 million promissory note with NorthView Sponsor I, making it convertible into equity at the greater of 95% of the closing price or $0.35 per share, extending its maturity to December 31, 2026, and removing interest. A 19.99% exchange cap was added, requiring shareholder approval for further conversion. Additionally, a warrant with Ascent Partners Fund was amended to remove automatic conversion provisions in fundamental transactions. This follows the company's recent 8-K filing on April 24th regarding obtaining convertible debt and warrants, and an S-1 filing on April 28th for the resale of 179.3 million shares, indicating significant potential dilution. These amendments are critical for Profusa, a company with a very low market cap and a going concern warning, as they restructure existing debt to provide more flexibility and comply with Nasdaq rules regarding dilution. While the conversion feature introduces potential dilution for existing shareholders, the 19.99% cap offers some near-term protection by requiring shareholder approval for further conversion. Investors should monitor the upcoming shareholder vote for approval of further conversions and any subsequent filings related to the company's ongoing financing needs and capital structure.

At the time of this announcement, PFSA was trading at $0.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.41 to $975.00. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Nov 13, 2026, 3:55 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.44199
Real-time Price: $0.3489 info
Change: -$0.09309 (-21%) info
Market Cap: $1.963M info
PFSA
Nov 12, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7158
Real-time Price: $0.3489 info
Change: -$0.3669 (-51%) info
Market Cap: $1.963M info
PFSA
Nov 10, 2026, 5:09 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.5203
Real-time Price: $0.3489 info
Change: -$0.1714 (-33%) info
Market Cap: $1.963M info
PFSA
Nov 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.530
Real-time Price: $0.3489 info
Change: -$0.1811 (-34%) info
Market Cap: $1.963M info
PFSA
Oct 15, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.26
Real-time Price: $0.3489 info
Change: -$0.9111 (-72%) info
Market Cap: $1.963M info